Systematic Literature Review and Quantitative Meta-Analysis
Pain Points (Public)
Researchers and clinical teams need rigorous evidence synthesis for high-impact journal submissions or regulatory reviews, but lack the bandwidth or specialized methodological expertise to execute PRISMA-compliant multi-database searches, dual-reviewer study screening, risk-of-bias assessments (e.g., RoB 2), and statistical pooling in R or RevMan.
Suggested Approach (Public)
Provide end-to-end evidence synthesis services encompassing comprehensive search strategy development across databases like PubMed and Embase, deduplication and screening via Covidence/Rayyan, rigorous quality appraisal, and statistical meta-analysis including heterogeneity testing, forest/funnel plot generation, and subgroup sensitivity analysis.
The analysis below is an AI-generated hypothesis awaiting editorial review. Scores and build verdicts are not verified recommendations.
Posted budgets are not confirmed payments. Task counts do not establish independent buyers or willingness to subscribe. Small samples are preliminary signals.
Opportunity assessment PRO
Development brief PRO
- Offer hands-on R (metafor) and RevMan statistical pooling as a high-touch methodological consultancy rather than launching standalone SaaS software directly.
- Standardized PRISMA literature screening pipeline with automated export compatibility for PubMed search strings.
Competitor evidence PRO
🛠️ Community Matching Tools
If you've built a product that solves this demand, you can submit it for showcase. 15 tokens are charged once approved; rejected submissions are never charged.
Public Demand Evidence · 2 task(s)
Only task summaries and outbound links are shown, never full-text reproduction; personal information has been scrubbed. Data sources are logged and traceable.
💬 Community Discussion